Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
Stephen Padilla, 4 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).

Factor XIII lower in decompensated cirrhosis patients with AKI

07 Oct 2019

Decompensated cirrhosis patients with acute kidney injury (AKI) tend to have factor XIII deficiency, a recent study suggests.

Researchers performed a prospective investigation of 43 hospitalized decompensated cirrhosis patients with (n=22; median age, 55 years; 50 percent male) or without (n=21; median age, 49 years; 52 percent male) AKI. Peripheral blood samples were collected and subjected to standard assays to measure factor XIII antigen concentrations, coagulation factor levels and thrombin generation, among other factors.

Compared to the non-AKI participants, factor XIII levels were significantly lower in the AKI patients (38 percent vs 60 percent; p=0.0002). Other coagulation factors, such as platelets (89,000/µL vs 87,000/µL; p=0.827) and fibrinogen (156 vs 151 mg/dL; p=0.743) were statistically comparable.

Similarly, the ratio between endogenous thrombin potential (ETP) without-to-with thrombomodulin was comparable between AKI and non-AKI patients (0.92 vs 0.93; p=0.183). However, comparing cirrhotic patients to healthy controls showed significantly reduced ETP ratio in the latter group (0.56; p=0.0001).

Differences in other thrombin generation assay parameters, such as total peak thrombin production and velocity of production, tended to be lower in participants with vs without AKI, but failed to reach statistical significance.

“The results support the paradigm of a rebalanced coagulation system in patients with cirrhosis that is vulnerable to exogenous disruption such as AKI,” said researchers. “Although this study does not prove causality, these results suggest that changes in factor XIII are a significant consideration in decompensated cirrhosis when associated with AKI.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
Stephen Padilla, 4 days ago
The Lancet Commission on Hypertension Group has recently released a position statement that contains a list of recommendations for the improvement of accuracy standards for devices that measure blood pressure (BP).